Actual 5-year survival of patients with stage IIIB breast carcinoma: Phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid

Cancer Investigation

Volumn 17, Issue 7, 1999, Pages 463-467

  Madajewicz, Stefan ^a,d   Matei, Daniele ^a   Hentschel, Patricia ^a   Kudelka, Andrzej ^b   Abel, William ^a   Fiore, John J ^a   DaCosta, Noshir A ^a   Pendyala, Lakshmi ^c  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MASTECTOMY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032837093     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909032854     Document Type: Article

References (19)

1. Hortobagyi GN, Singletary SE, McNeese MD: Treatment of locally advanced and inflammatory breast cancer. In: Diseases of the Breast, edited by ME Lippman, M Marrow, S Hellman, Philadelphia, Lippincott-Raven, 1996, pp. 585-599.
2. DeLena M, Zucali R, Viganotti G, et al: Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chem Pharm 1:53-59, 1978.
3. Hortobagyi GN, Blumenschein GR, Spanos W, et al: Multimodal treatment of locoregionally advanced breast cancer. Cancer 51: 763-768, 1983.
4. Sledge GW Jr, Loehrer PJ, Roth BJ, et al: Cisplatin as first-line therapy for metastatic breast cancer. Proc Am Soc Clin Oncol 6: 206, 1987.
5. Kolaric K, Vukas D, Roth A, et al: Cyclophosphamide, adriamycin and platinum (CAP) combination chemotherapy, a new effective approach in the treatment of disseminated breast cancer. Preliminary report. Tumori 71:159-165, 1985.
6. Cocconi G, Bisagni G, Bacchi M, et al: Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research. J Clin Oncol 9:664-669, 1991.
7. Sternberg CN, Yagoda A, Scher HI, et al: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133:403-407, 1985.
8. DeLena M, Varini M, Zucoli R, et al: Multimodal treatment for locally advanced breast cancer. Result of chemotherapy radiotherapy versus chemotherapy-surgery. Cancer Clin Trials 4:229-236, 1981.
9. Hortobagyi GN, Ames FC, Buzdar AU, et al: Management of stage III primary breast cancer with primary chemotherapy surgery, and radiation therapy. Cancer 62:2507-2516, 1988.
10. Ueno NT, Buzdar AU, Singletary FC, et al: Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother Pharmacol 40:321-329, 1997.
11. Swain SM, Lippman ME: Treatment of patient with inflammatory breast cancer. In: Important Adv Oncol, edited by VT DeVita Jr, S Hellman, SA Rosenberg, Philadelphia, J.B. Lippincott Company, 1989, pp. 129-150.
12. Kolaric K, Vukas D, Potrebica V. CAP (cyclophosphamide, adriamycin, platinum) vs. FAC (5-fluorouracil, adriamycin cyclophosphamide) combination chemotherapy in metastatic breast cancer patients - a preliminary report. Proc Am Soc Clin Oncol 5:299, 1986.
13. Jones AL, Smith IE, O'Brien MER, et al: Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen. J Clin Oncol 12:1259-1265, 1994.
14. Roth BJ, Sledge GW, Williams SD, et al: Methotrexate vinblastine, doxorubicin, and cisplatin (M-VAC) as first-line chemotherapy (CT) in metastatic breast cancer (MBC): a phase II trial of the Hoosier Oncology Group. Proc Am Soc Clin Oncol 7:118, 1988.
15. Langer CJ, Catalano R, Weiner LM, et al: Phase II evaluation of methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) in advanced, measurable breast carcinoma. Cancer Invest 13:150-159, 1995.
16. Kudelka A, Abel W, Berken A, et al: Phase II trial of methotrexate, vinblastine, doxorubicin, cisplatin and folinic acid (MVAC/ FA) in the treatment of locally advanced and metastatic breast cancer: an update. Proc Am Soc Clin Oncol 8:194, 1989.
17. Jahnke L, Winter J: High-dose therapy's role in breast cancer management. Contemp Oncol 3:38-49,1993.
18. Peters WP: High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes [review]. In: Important Adv Oncol, edited by VT DeVita Jr, S Hellman, SA Rosenberg, Philadelphia, J.B. Lippincott Company, 1995, pp. 215-230.
19. Smith GA, Henderson IC: High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out [review]. In: Important Adv Oncol, edited by VT DeVita Jr, S Hellman, SA Rosenberg, Philadelphia, J.B. Lippincott Company, 1995, pp. 201-214.